Connect with us

Health

Cannabis and Cocaine Top Drug Use in the EU, but Other Substances Pose Rising Risks

Published

on

Cannabis and cocaine remain the most commonly used drugs across the European Union, but other substances are emerging as significant public health threats, according to a joint report by the European Commission and the Organisation for Economic Co-operation and Development (OECD).

Nearly one in three Europeans have tried illegal drugs at some point in their lives. Regular drug use is linked to heightened risks of cardiovascular disease, mental health problems, accidents, and infectious diseases like HIV, particularly with injectable substances.

Cannabis and Cocaine Usage

Cannabis use is especially prevalent among young adults, with 15% reporting consumption in the past year. Among all age groups, the highest rates of cannabis use were found in the Czech Republic, Italy, France, and Spain. In contrast, Malta, Turkey, and Hungary reported the lowest rates.

Cocaine use is less common but remains significant, with 2.5% of young adults reporting use in the past year. The Netherlands, Spain, and Ireland report the highest rates of cocaine use, while Turkey, Portugal, Poland, and Hungary show the lowest prevalence.

Law Enforcement Impact

Strict drug penalties appear to have limited influence on drug availability for younger populations. “The major penalties impact only the people who use the substance once or fewer times in a year, so not the real [heavy] users,” explained Sabrina Molinaro, an epidemiologist and research director at Italy’s National Research Council.

Drug habits among youth often predict adult trends, Molinaro noted. Historically, boys were more likely than girls to use cannabis, but that gap has narrowed in recent years, with girls surpassing boys in some countries.

Growing Risks from Other Drugs

While cannabis and cocaine dominate drug use in the EU, substances like MDMA (ecstasy), heroin, opioids, psychedelics, and synthetic drugs are emerging as critical threats. Synthetic drugs, including lab-made cannabinoids and stimulants, pose unique challenges because they are difficult to identify and regulate quickly.

“They are so dangerous [because] you don’t know what you are taking,” said Molinaro, emphasizing the risks posed by low-quality manufacturing and potential contamination.

The EU dismantled hundreds of synthetic drug labs in 2022, and its early warning system identified seven new synthetic opioid substances in 2023, noted for their potency and health risks.

Public Health Concerns

Synthetic drugs, in particular, are a growing issue among adult populations, according to Molinaro. With the rise in new substances and increasing drug availability, experts are calling for more robust measures to address these evolving challenges.

The report underscores the need for comprehensive approaches to tackle drug use and its health implications across the EU, including better monitoring, education, and targeted interventions.

Health

Cannabis and Cocaine Lead Drug Use in EU, Synthetic Substances Pose Growing Threat

Published

on

By

Cannabis and cocaine remain the most commonly used illegal drugs across the European Union, but other substances, including synthetic drugs, are emerging as significant public health concerns, according to a joint report by the European Commission and the Organisation for Economic Co-operation and Development (OECD).

Nearly one in three Europeans have tried illegal drugs at some point, with younger populations showing notable usage patterns. Among young adults, 15% reported using cannabis in the past year, while 2.5% admitted to using cocaine. The highest rates of cannabis use were observed in the Czech Republic, Italy, France, and Spain, while Malta, Turkey, and Hungary reported the lowest. Similarly, cocaine use was most prevalent in the Netherlands, Spain, and Ireland and least common in Turkey, Portugal, Poland, and Hungary.

Regular drug use is linked to serious health risks, including cardiovascular disease, mental health disorders, accidents, and infectious diseases such as HIV, particularly among users of injectable drugs.

Drug Availability Unaffected by Penalties

Despite varying drug enforcement policies across EU member states, the availability of illegal substances remains largely unaffected, especially among young people. Sabrina Molinaro, an epidemiologist and research director at Italy’s National Research Council, emphasized that strict penalties often fail to target heavy users effectively.

“The major penalties impact only the people who use the substance once or fewer times in a year, so not the real heavy users,” Molinaro explained.

Molinaro, who coordinates the European School Survey Project on Alcohol and Other Drugs, noted that drug use trends among 16-year-olds have remained consistent over decades. For instance, while boys have historically been more likely to use cannabis, the gender gap has narrowed significantly, with some countries even reporting higher usage rates among girls.

Emerging Risks from Synthetic Drugs

While cannabis and cocaine dominate, other substances like MDMA (ecstasy), heroin, and synthetic drugs pose escalating risks. Synthetic drugs, including lab-manufactured cannabinoids and stimulants, are particularly concerning due to their unpredictable composition and potential for contamination.

“They are so dangerous because you don’t know what you are taking,” Molinaro warned, adding that these substances are often produced in substandard labs, increasing the risk of harmful pollutants.

In 2022, hundreds of synthetic drug labs were dismantled across the EU. The following year, the EU’s early warning system identified seven new synthetic opioid substances, underscoring the challenges authorities face in regulating these compounds swiftly.

“Synthetic opioids are a very big health issue in the adult population,” Molinaro said.

As drug usage trends continue to evolve, experts emphasize the need for robust monitoring, public awareness, and targeted interventions to mitigate the health risks associated with drug use across Europe.

Continue Reading

Health

Air Pollution Linked to 239,000 Deaths in Europe, Highlighting Regional Disparities

Published

on

By

Air pollution continues to pose a significant public health threat across Europe, with fine particulate matter (PM2.5) contributing to approximately 239,000 premature deaths in 2021, according to the European Environment Agency (EEA). The impact of air pollution varies widely across the continent, with Central and Eastern Europe bearing the brunt of the health burden.

Fine particulate matter, including dust, smoke, and soot, is linked to numerous health problems such as lung cancer, heart and respiratory diseases, stroke, and poor birth outcomes. Among older adults aged 65 and above, it accounts for about 4% of all deaths. Exposure to nitrogen dioxide (NO₂), largely driven by traffic and industrial emissions, led to an additional 48,000 deaths in the same year.

Efforts to address these issues intensified in 2021 when the World Health Organization (WHO) revised its air quality guidelines, setting stricter thresholds for PM2.5 and NO₂ concentrations. This month, the European Union implemented new air quality rules aiming to align closer with WHO standards by 2030. These measures include monitoring pollutants like black carbon and ammonia, marking what experts describe as a critical intervention for public health.

Mark Nieuwenhuijsen, director of the urban planning, environment, and health initiative at the Barcelona Institute for Global Health, called the EU plan “one of the biggest public health interventions for a generation.”

Regional Variations in Impact

A report by the European Commission and the Organisation for Economic Co-operation and Development (OECD) highlighted stark regional disparities. Central and Eastern Europe reported the highest death rates linked to PM2.5, attributed largely to residential coal burning and agricultural emissions. Northern Italy, Poland, and the Czech Republic are among the regions most affected.

Meanwhile, NO₂-related mortality was highest in major urban centers and capital cities in Western and Southern Europe, driven by vehicle traffic and industrial activities.

Environmental epidemiology professor Zorana Jovanovic Andersen noted that these disparities align closely with socioeconomic factors, underscoring the divide between eastern and western Europe.

Progress and Challenges

The EU directive allows citizens affected by pollution-related health issues to take legal action against non-compliant governments. While the EU is on track to reduce PM2.5-linked deaths by 55% by 2030, scientists warn that air pollution remains a growing threat, intertwined with climate change, noise pollution, and a lack of green spaces.

“We know how to reduce air pollution, and many countries are leading,” Andersen said. “But there are new challenges, so we need to regulate air pollution—the old problem.”

With its wide-reaching health and environmental implications, air pollution remains a top priority for policymakers seeking to protect public health across Europe.

Continue Reading

Health

King Charles III Thanks Health Workers in Heartfelt Christmas Message Amid Cancer Diagnoses in Royal Family

Published

on

By

In his 2024 Christmas message, King Charles III expressed profound gratitude to health workers who supported him and his family through a challenging year marked by two cancer diagnoses.

The 76-year-old monarch, speaking in a pre-recorded address, praised the dedication of medical professionals. “From a personal point of view, I offer special, heartfelt thanks to the selfless doctors and nurses who this year have supported me and other members of my family through the uncertainties and anxieties of illness and have helped provide the strength, care, and comfort we have needed,” he said.

A Challenging Year

Earlier this year, Buckingham Palace revealed that King Charles had been diagnosed with an undisclosed form of cancer in February, prompting a two-month hiatus from public duties. The monarch has since resumed engagements, including an October tour of Australia and the South Pacific, where he appeared in good spirits.

Shortly after the King’s diagnosis, the Princess of Wales, Kate Middleton, also announced her own battle with cancer. Kate, who completed chemotherapy this year, has gradually returned to public life. On Christmas Day, she attended services at Sandringham alongside other senior royals, where she embraced a cancer patient in a touching moment of solidarity.

In her annual Christmas carol service broadcast from Westminster Abbey, Kate reflected on the challenges of the year, emphasizing the importance of empathy. “The Christmas story encourages us to consider the experiences and feelings of others. It also reflects our own vulnerabilities and reminds us of the importance of giving and receiving empathy, as well as just how much we need each other in spite of our differences,” she said.

Broader Reflections

The King’s address also touched on global and domestic issues. He spoke about the “devastating effects of conflict” in regions such as the Middle East, Central Europe, and Africa, underscoring the toll of war on communities worldwide.

On the home front, he praised the resilience of communities that came together in the wake of riots sparked by a tragic stabbing attack at a dance class, which left three girls dead and several others injured.

Royal Family’s Public Appearance

Earlier on Christmas Day, the King, Queen Camilla, and other senior royals attended church services in Sandringham. The family walked together, greeting well-wishers who had gathered to see them.

This year marks King Charles III’s third Christmas address since ascending the throne in September 2022 following the death of Queen Elizabeth II. His heartfelt message highlighted the importance of unity, resilience, and gratitude during trying times, resonating with audiences across the nation.

Continue Reading

Trending